Company Overview of Conatus Pharmaceuticals Inc.
Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. Its products include Emricasan, an orally active pan-caspase protease inhibitor, which is in Phase 2 clinical trials for the treatment of liver cirrhosis, acute-on-chronic liver failure, post liver transplant clearance of hepatitis C virus infection with sustained viral response, non-alcoholic steatohepatitis, and nonalcoholic fatty liver disease. The company was founded in 2005 and is headquartered in San Diego, California.
16745 West Bernardo Drive
San Diego, CA 92121
Founded in 2005
Key Executives for Conatus Pharmaceuticals Inc.
Conatus Pharmaceuticals Inc. Key Developments
Similar Private Companies By Industry
|Alkira Therapeutics, Inc.||United States|
|ProMed Pharma, LLC||United States|
|TransGenex Nanobiotech, Inc.||United States|
|Prospex Medical III, Inc.||United States|
|Nutraceutical Research Innovations LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Conatus Pharmaceuticals Inc., please visit www.conatuspharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.